In April 2022, I started working on the launch of Lilly’s groundbreaking new Alzheimer’s medication, Kisunla (donanemab). When launch day came in early July 2024, we were ready. Thanks to our work, my team won “Best Launch of 2024” at AREA 23’s annual Hero Awards—and I took home a Hero Award myself.

You can check out the branded and unbranded websites I worked on for Lilly Alzheimer’s and Kisunla. These sites feature are a great showcase of all the copy I helped craft, making a complex subject easy to understand for potential patients.

Kisunla website: https://kisunla.lilly.com

Disease Education (DSE) website: https://morethannormalaging.lilly.com